Kanakion Mm

Phytomenadione, the active ingredient in Kanakion Mm, is a vitamin K presented as a sterile solution for intravenous and oral use. It restores normal clotting in patients with vitamin K deficiency, supports treatment of anticoagulant‑related bleeding, and is used for neonatal prophylaxis of hemorrhagic disease. GNH USA supplies Kanakion Mm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kanakion Mm provides vitamin K activity to address disorders of coagulation. - Vitamin K deficiency: restores functional clotting factor synthesis in deficient patients. - Anticoagulant‑related bleeding: counteracts excess anticoagulation to reduce hemorrhage risk. - Neonatal hemorrhagic disease prophylaxis: prevents bleeding in newborns at risk of vitamin K deficiency.

Phytomenadione may cause adverse reactions in some patients.

Common Side Effects: - Injection site pain or erythema - Nausea or mild gastrointestinal upset - Headache or dizziness - Transient flushing - Mild fever - Elevated liver enzymes

Serious or Rare Side Effects: - Anaphylactic reaction - Severe bleeding or thrombosis - Hemolytic anemia - Acute renal failure - Hypotension - Pulmonary edema

Use Phytomenadione with clinical vigilance to minimize risks. - Assess vitamin K status: evaluate baseline coagulation before therapy. - Monitor coagulation parameters: check PT/INR regularly during treatment. - Use cautiously with anticoagulants: adjust dosing as needed. - Avoid in known hypersensitivity to phytomenadione or excipients. - Store at ambient temperature: keep in original container, protect from moisture and light.

Phytomenadione can alter the effects of several medications.

Major Interactions (Avoid): - Warfarin: may reduce anticoagulant effect, increasing clot risk. - Broad‑spectrum antibiotics: can disrupt gut flora, affecting vitamin K levels.

Moderate Interactions (Monitor Closely): - Heparin: additive anticoagulant effect may increase bleeding. - Oral contraceptives: potential increased thrombosis risk. - Vitamin E supplements: may interfere with vitamin K metabolism.